ABBV
AbbVie Inc. · Healthcare · Drug Manufacturers - General
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +4.6% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 181 | +6 | 1.06B | $267.14B | +9 | −4 |
| Q1 2026 | 179 | -3 | 1.05B | $227.15B | +2 | −6 |
| Q4 2025 | 181 | -3 | 1.14B | $259.75B | +1 | −3 |
| Q3 2025 | 27 | 0 | 673.15M | $155.83B | n/a | −1 |
| Q2 2025 | 25 | +2 | 519.81M | $96.45B | +2 | n/a |
| Q1 2025 | 20 | 0 | 175.76M | $36.80B | n/a | n/a |
| Q4 2024 | 20 | 0 | 178.61M | $31.72B | n/a | n/a |
| Q3 2024 | 19 | 0 | 95.00M | $18.73B | +1 | −1 |
| Q2 2024 | 19 | n/a | 90.79M | $15.55B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passief) | 36.16M | -1.4% | $7.12B | 0.6% | ▼ Trim | 2 | SEC ↗ ×2 |
| 2 | Norges Bank ✦ (passief) | 22.98M | +2.2% | $4.54B | 0.6% | ▲ Add | 2 | SEC ↗ |
| 3 | Capital World Investors ✦ | 15.45M | +50.2% | $3.05B | 0.5% | ▲ Add | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 10.26M | -6.3% | $2.03B | 0.2% | ▼ Trim | 2 | SEC ↗ ×2 |
| 5 | AQR Capital Management ✦ | 1.71M | +21.9% | $333.25M | 0.5% | ▲ Add | 2 | SEC ↗ ×3 |
| 6 | Adage Capital Partners ✦ | 1.66M | +16.7% | $327.38M | 0.6% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.57M | -45.6% | $309.48M | 0.1% | ▼ Trim | 2 | SEC ↗ ×6 |
| 8 | Marshall Wace ✦ | 1.33M | +50.0% | $262.48M | 0.3% | ▲ Add | 2 | SEC ↗ ×2 |
| 9 | Renaissance Technologies ✦ | 1.14M | -12.8% | $224.65M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 10 | Millennium Management ✦ | 1.09M | +11.7% | $216.24M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 626.91K | -31.8% | $123.80M | 0.2% | ▼ Trim | 2 | SEC ↗ ×2 |
| 12 | Arrowstreet Capital ✦ | 459.15K | +150.8% | $90.67M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 247.19K | Nieuw | $48.82M | 0.1% | New | 1 | SEC ↗ ×2 |
| 14 | Bridgewater Associates ✦ | 204.57K | -29.1% | $40.40M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 45.69K | -0.8% | $9.02M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 16 | Fisher Asset Management ✦ | 38.91K | -2.2% | $7.68M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | GAMCO Investors ✦ | 13.61K | -7.7% | $2.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Dodge & Cox ✦ | 11.01K | 0.0% | $2.17M | 0.0% | Held | 2 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 7.40K | -56.6% | $1.46M | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Citadel Advisors | $48.82M | 0.1% |
Verlaten
| Harris Associates (Oakmark) | $256,079 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 4,042 houders, 1.24B aandelen, $260.03B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 32.71K aand · $8.18M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie